Detalles de la búsqueda
1.
Anthracycline-containing regimens or taxane versus S-1 as first-line chemotherapy for metastatic breast cancer.
Br J Cancer
; 125(9): 1217-1225, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480096
2.
Ki-67 response-guided preoperative chemotherapy for HER2-positive breast cancer: results of a randomised Phase 2 study.
Br J Cancer
; 122(12): 1747-1753, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32238920
3.
T-bet+ lymphocytes infiltration as an independent better prognostic indicator for triple-negative breast cancer.
Breast Cancer Res Treat
; 176(3): 569-577, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31069590
4.
Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study.
Breast Cancer Res Treat
; 176(3): 631-635, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31115845
5.
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patients.
Int J Clin Oncol
; 24(3): 274-287, 2019 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-30515674
6.
Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study.
Cancer Sci
; 109(3): 803-813, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29345736
7.
Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab.
Oncology
; 93(1): 51-61, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28478451
8.
Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial.
Lancet Oncol
; 17(1): 90-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26617202
9.
A Comparison of the Hot Spot and the Average Cancer Cell Counting Methods and the Optimal Cutoff Point of the Ki-67 Index for Luminal Type Breast Cancer.
Oncology
; 90(1): 43-50, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26613521
10.
Efficacy of intraoperative entire-circumferential frozen section analysis of lumpectomy margins during breast-conserving surgery for breast cancer.
Int J Clin Oncol
; 20(6): 1093-101, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25855313
11.
Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients.
Int J Clin Oncol
; 20(4): 709-22, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25666483
12.
[Efficacy and safety of TS-1 monotherapy for advanced/metastatic breast cancer - an observational study by the Kumamoto Breast Cancer Cooperative Group(KBCCG)].
Gan To Kagaku Ryoho
; 41(10): 1221-5, 2014 Oct.
Artículo
en Japonés
| MEDLINE | ID: mdl-25335703
13.
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes.
Clin Breast Cancer
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472058
14.
Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer.
Cancer
; 119(4): 704-13, 2013 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22972694
15.
Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).
Breast Cancer Res Treat
; 137(1): 93-107, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23160924
16.
Breast cancer subtype and distant recurrence after ipsilateral breast tumor recurrence.
Ann Surg Oncol
; 20(6): 1886-92, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23292516
17.
Evaluation of factors related to late recurrence--later than 10 years after the initial treatment--in primary breast cancer.
Oncology
; 85(2): 100-10, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23867253
18.
A multicenter, phase II study of epirubicin/cyclophosphamide followed by docetaxel and concurrent trastuzumab as primary systemic therapy for HER-2 positive advanced breast cancer (the HER2NAT study).
Int J Clin Oncol
; 18(4): 598-606, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22833344
19.
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
Lancet Oncol
; 13(4): 345-52, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22265697
20.
A prospective analysis of two studies that used the 5-mm interval slices and 5-mm margin-free method for ipsilateral breast tumor recurrence after breast-conserving surgery without radiotherapy.
Breast Cancer
; 30(1): 131-138, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36175750